Bengaluru, India

Mujeebur Rahman


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Mujeebur Rahman: Innovator in Medicinal Interactions

Introduction

Mujeebur Rahman is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal interactions, particularly in the context of online clinical trials. His innovative approach aims to enhance the understanding of how natural medicines interact with modern medicines.

Latest Patents

Mujeebur holds a patent for "Identifying potential medicinal interactions for online clinical trial study groups." This patent outlines techniques for identifying interactions between natural and modern medicines. The process involves analyzing a corpus of information related to these interactions for treating specific conditions. A mapping is created to connect natural medicines with modern medicines, facilitating better treatment options. Additionally, an online clinical trial study group is established, allowing selected users to participate based on their medication usage profiles. Information collected from participants is then analyzed to improve understanding and outcomes.

Career Highlights

Mujeebur Rahman is currently associated with International Business Machines Corporation, commonly known as IBM. His work at IBM focuses on leveraging technology to advance medicinal research and clinical trials. His innovative contributions have positioned him as a key figure in the intersection of technology and healthcare.

Collaborations

Some of Mujeebur's coworkers include Anca Sailer and Kevin Paul Julier. Their collaborative efforts contribute to the ongoing research and development in the field of medicinal interactions.

Conclusion

In summary, Mujeebur Rahman is a pioneering inventor whose work in identifying medicinal interactions is paving the way for advancements in clinical trials. His contributions are vital for improving treatment methodologies and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…